3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
venetoclax
45
Cyclophosphamide
43
Specimen Handling
41
Cytarabine
39
fludarabine
31
Biopsy
30
Azacitidine
24
Rituximab
20
Methotrexate
17
fludarabine phosphate
16
blinatumomab
15
Vincristine
15
Dexamethasone
14
Daunorubicin
14
ibrutinib
13
Prednisone
13
Magnetic Resonance Spectroscopy
13
Whole-Body Irradiation
12
Injections
12
obinutuzumab
11
merphos
11
Mercaptopurine
11
Calcium Dobesilate
11
Mycophenolic Acid
10
Filgrastim
10
Doxorubicin
10
X-Rays
9
Tacrolimus
9
Leucovorin
9
Etoposide
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Roflumilast
×
Other hematologic neoplasm
×
30 days
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled